Hematopoietic Stem-Like Cells therapy(New World Laboratories)

N/A

Report date: 2024/11/01 14:35:32

Base Information

Drug NameHematopoietic Stem-Like Cells therapy(New World Laboratories)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsHematologic DiseasesLeukemiaAcquired Immunodeficiency Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew World Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesNew World Laboratories
Inactive CompaniesN/A
Active IndicationsHematologic DiseasesLeukemiaAcquired Immunodeficiency Syndrome +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A